ArticleNature communications2018
Nuclear receptor NR2F6 inhibition potentiates responses to PD-L1/PD-1 cancer immune checkpoint blockade.
Victoria Klepsch et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
47 papers cite it
this papercites it